STANDIGM
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactoryâ„¢, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASKâ„¢ for target discovery, Standigm BESTâ„¢ for lead design, and Standigm Insightâ„¢ for drug repurposing.
STANDIGM
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Machine Learning Pharmaceutical
Founded:
2015-05-04
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.standigm.com
Total Employee:
101+
Status:
Active
Contact:
82-2-501-8118
Email Addresses:
[email protected]
Total Funding:
71.49 M USD
Technology used in webpage:
Amazon Global Site Tag HSTS Google Analytics 4 Nginx Ubuntu AWS Global Accelerator Java EE Amazon Oregon Region Material-UI
Similar Organizations
AIGEN Sciences
AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Pumeirui Biotechnology
Pumeirui Biotechnology is a developer of drug discovery algorithm platforms for improving the efficiency of drug development.
StoneWise
StoneWise is committed to establishing the world's leading intelligent drug discovery platform.
Swoop
Swoop uses privacy-safe advanced technology and AI to find, activate, engage and optimize ideal DTC and HCP audiences.
Zai Lab
Zai Lab brings transformative medicines for cancer, autoimmune, and infectious diseases to patients in China and around the world.
Current Employees Featured
Founder
Investors List
Pavilion Capital
Pavilion Capital investment in Series D - Standigm
SK geo centric
SK geo centric investment in Corporate Round - Standigm
Kakao Ventures
Kakao Ventures investment in Series C - Standigm
KDB Bank Europe
KDB Bank Europe investment in Series C - Standigm
Atinum Partners
Atinum Partners investment in Series C - Standigm
SKS PE
SKS PE investment in Series C - Standigm
WONIK Investment Partners
WONIK Investment Partners investment in Series C - Standigm
Asset One
Asset One investment in Series C - Standigm
DSC Investment
DSC Investment investment in Series C - Standigm
InterVest Co.
InterVest Co. investment in Series C - Standigm
Newest Events participated
Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany
on 2017-11-06 as speaker
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-18 | Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery |
Official Site Inspections
http://www.standigm.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.63 K
- Host name: 104.26.2.20
- IP address: 104.26.2.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Standigm"
Standigm
Aug 31, 2021 About Standigm. Standigm harnesses the power of AI to pioneer drug discovery, developing both proprietary and collaborative research pipelines. Our AI platform approach …See details»
Standigm - Crunchbase Company Profile & Funding
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable …See details»
Standigm - LinkedIn
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable …See details»
Standigm Company Profile 2024: Valuation, Funding & Investors
Standigm General Information Description. Developer of artificial intelligence software designed to encompass novel target identification to generate commercially valuable drug pipelines. The …See details»
Standigm
Feb 1, 2023 Standigm, AI for new drug R&D. Jinhan Kim is the CEO of Standigm, a workflow AI drug discovery company. From customized target identification to lead generation, the …See details»
Standigm
Aug 18, 2022 Veteran biotech and pharmaceutical executive will help company increase its growth and international impact SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- …See details»
Standigm - Funding, Financials, Valuation & Investors - Crunchbase
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development. ... Solutions. Products. Resources. Pricing. …See details»
Standigm Company Profile - Office Locations, Competitors ... - Craft
Standigm has 5 employees across 3 locations and $69.69 m in total funding,. See insights on Standigm including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Standigm named as a Tech Innovator in Generative AI in Drug …
Dec 19, 2023 Standigm ASK, an AI-aided drug ... Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. …See details»
Standigm - VentureRadar
Standigm is a workflow artificial intelligence (AI) drug discovery company bringing a revolution to your drug discovery journey. From customized target identification to lead generation, our …See details»
Standigm - Contacts, Employees, Board Members, Advisors
Standigm is an AI-driven workflow drug discovery company that aims to improve the success rates and efficiency of new drug development. ... Products. Resources. Pricing. Resources. …See details»
Standigm cited as 'Top 10 Generative AI-based startup based on …
Jan 5, 2023 Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report By . Published : Jan. 6, 2023 - 00:11See details»
Standigm cited as 'Top 10 Generative AI-based startup based on …
Jan 5, 2023 Standigm ranked seventh of 10 Generative AI-based startups based on its level of VC funding. What generative AI is, and how it's used in drug discovery Generative AI uses …See details»
Jinhan Kim, CEO of Standigm - Interview Series - Unite.AI
Feb 1, 2023 Jinhan Kim is the CEO of Standigm, a workflow AI drug discovery company. From customized target identification to lead generation, the Standigm workflow AI platform …See details»
Standigm and Institut Pasteur Korea Identify Lead Compounds for ...
Apr 4, 2023 Standigm, the project's lead organization, utilized its drug design artificial intelligence platform, Standigm BESTâ„¢, with a scaffold-based molecular generation model …See details»
Standigm Secures Strategic Investment from SK Chemicals for …
Jul 2, 2021 SK Chemicals-Standigm will collaborate for the development of Standigm’s AI-driven drug candidate; Standigm will open its own Synthetic Research Center to facilitate drug …See details»
Health Tech: Jinhan Kim On How Standigm’s AI Technology Can
Jun 10, 2022 Standigm Co-Founder, Chairman, and CEO Jin Han Kim is an expert in developing AI platforms to identify new drug candidates and has led the company since its inception in …See details»
Standigm
If you have your own unique target, collaborating with Standigm will make your drug discovery journey more efficient. Standigm suggests a commercially available compound structures with …See details»
News & Event - standigm.com
Standigm's Synthetic Research Center is now being used to accelerate the progress of novel and promising projects. The company's in-house scientists are working with external contact …See details»
Standigm
Aug 31, 2021 Standigm ASK TM is an AI-aided drug target identification platform ready to be customized to your research context. It provides not only a prioritized target list for query …See details»